| Lipid metabolism reprogramming and its potential targets in cancer C Cheng, F Geng, X Cheng, D Guo Cancer communications 38, 1-14, 2018 | 676 | 2018 |
| The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation T Liu, Q Wei, J Jin, Q Luo, Y Liu, Y Yang, C Cheng, L Li, J Pi, Y Si, H Xiao, ... Nucleic acids research 48 (7), 3816-3831, 2020 | 572 | 2020 |
| Metabolism of Amino Acids in Cancer Z Wei, X Liu, C Cheng, W Yu, P Yi Front. Cell Dev. Biol. 8, 1628, 2021 | 315 | 2021 |
| Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ... Clinical Cancer Research 22 (21), 5337-5348, 2016 | 293 | 2016 |
| Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth C Cheng, P Ru, F Geng, J Liu, JY Yoo, X Wu, X Cheng, V Euthine, P Hu, ... Cancer cell 28 (5), 569-581, 2015 | 274 | 2015 |
| Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress X Cheng, F Geng, M Pan, X Wu, Y Zhong, C Wang, Z Tian, C Cheng, ... Cell metabolism 32 (2), 229-242. e8, 2020 | 229 | 2020 |
| Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis J Xu, EYM Wong, C Cheng, J Li, MTK Sharkar, CY Xu, B Chen, J Sun, ... Developmental cell 31 (4), 434-447, 2014 | 137 | 2014 |
| Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer Y Wang, Y Wang, Y Ren, Q Zhang, P Yi, C Cheng Seminars in cancer biology 86, 542-565, 2022 | 98 | 2022 |
| Feedback loop regulation of SCAP/SREBP-1 by miR-29 modulates EGFR signaling-driven glioblastoma growth P Ru, P Hu, F Geng, X Mo, C Cheng, JY Yoo, X Cheng, X Wu, JY Guo, ... Cell reports 16 (6), 1527-1535, 2016 | 88 | 2016 |
| Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth C Cheng, F Geng, Z Li, Y Zhong, H Wang, X Cheng, Y Zhao, X Mo, ... Nature metabolism 4 (5), 575-588, 2022 | 57 | 2022 |
| Current Status of Xenotransplantation Research and the Strategies for Preventing Xenograft Rejection Q Zhou, T Li, K Wang, Z Qi, Z Geng, S Deng, C Cheng, Y Wang Frontiers in Immunology, https://doi.org/10.3389/fimmu.2022.92817, 2022 | 43 | 2022 |
| Trihydrophobin 1 interacts with PAK1 and regulates ERK/MAPK activation and cell migration C Cheng, X Kong, H Wang, H Gan, Y Hao, W Zou, J Wu, Y Chi, J Yang, ... Journal of Biological Chemistry 284 (13), 8786-8796, 2009 | 40 | 2009 |
| EYA1's conformation specificity in dephosphorylating phosphothreonine in Myc and its activity on Myc stabilization in breast cancer J Li, Y Rodriguez, C Cheng, L Zeng, EYM Wong, CY Xu, MM Zhou, PX Xu Molecular and cellular biology 37 (1), e00499-16, 2017 | 39 | 2017 |
| HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation J Yang, Y Hong, W Wang, W Wu, Y Chi, H Zong, X Kong, Y Wei, X Yun, ... FEBS letters 583 (9), 1409-1414, 2009 | 34 | 2009 |
| Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma Q Zhou, Q Zhang, K Wang, T Huang, S Deng, Y Wang, C Cheng Pharmacological Research 178, 106181, 2022 | 22 | 2022 |
| Analysis of SCAP N-glycosylation and Trafficking in Human Cells C Cheng, JY Guo, F Geng, X Wu, X Cheng, Q Li, D Guo Journal of Visualized Experiments: Jove, 54709, 2016 | 19 | 2016 |
| CDK11p58 Phosphorylation of PAK1 Ser174 Promotes DLC2 Binding and Roles on Cell Cycle Progression X Kong, H Gan, Y Hao, C Cheng, J Jiang, Y Hong, J Yang, H Zhu, Y Chi, ... Journal of biochemistry 146 (3), 417-427, 2009 | 17 | 2009 |
| The transcriptional coactivator Eya1 exerts transcriptional repressive activity by interacting with REST corepressors and REST-binding sequences to maintain nephron progenitor … J Li, C Cheng, J Xu, T Zhang, B Tokat, G Dolios, A Ramakrishnan, L Shen, ... Nucleic Acids Research, 2022 | 6 | 2022 |
| Glutamine-released ammonia acts as an unprecedented signaling molecule activating lipid production C Cheng, S Kelsey, D Guo Genes & Diseases, 2022 | 4 | 2022 |
| Potential therapies targeting nuclear metabolic regulation in cancer Y Chen, J Xu, X Liu, L Guo, P Yi, C Cheng MedComm, 2023 | 3 | 2023 |